Chemomab Therapeutics Ltd...

2.05
-0.03 (-1.44%)
At close: Jan 28, 2025, 3:00 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -24.22M -27.65M -12.48M -5.95M -27.21M -13.80M -9.81M -4.73M -7.50M
Depreciation & Amortization 66.83K 58.00K 34.00K 24.00K 281.91K 66.00K 51.00K 40.64K 26.25K
Stock-Based Compensation 1.49M 3.21M 2.02M 130.00K 135.00K 125.00K n/a n/a n/a
Other Working Capital 222.52K 3.65M -3.12M 487.00K 1.23M -215.00K 41.00K 881.01K -137.96K
Other Non-Cash Items -2.27K 2.96M 912.63K 579.00K 2.96M 6.27M 805.00K 918.26K 574.23K
Deferred Income Tax n/a -2.96M -912.63K -579.00K 2.82M n/a n/a n/a n/a
Change in Working Capital -945.56K 4.01M -1.95M 555.00K 4.63M -3.42M 289.00K 506.67K -283.12K
Operating Cash Flow -23.61M -20.37M -12.37M -5.24M -16.51M -14.22M -8.52M -3.72M -7.38M
Capital Expenditures -3.00K -68.00K -239.00K -38.00K -95.31K -213.00K -34.00K -75.81K -87.25K
Acquisitions n/a n/a n/a 136.00K n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a -45.95M -24.00K n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a 19.60M n/a -135.98K n/a n/a n/a 153.43K 1.21M
Other Investing Acitivies 15.88M 19.60M 1.00M -24 n/a 2.00K n/a n/a n/a
Investing Cash Flow 15.88M 19.53M -45.19M -62.00K -95.31K -213.00K -34.00K 77.63K 1.12M
Debt Repayment n/a n/a n/a n/a n/a 16.94K n/a n/a n/a
Common Stock Repurchased n/a -1.22M n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies n/a 143.00K 2.44M 1.25M 26.71M n/a -40.70K -20.39K -115.04K
Financial Cash Flow 3.50M -808.00K 61.07M 4.75M 26.71M 20.62M 5.24M 6.04M 4.47M
Net Cash Flow -4.23M -1.65M 3.51M -554.00K 10.06M 6.06M -3.11M 2.39M -1.79M
Free Cash Flow -23.61M -20.44M -12.61M -5.28M -16.61M -14.44M -8.55M -3.80M -7.47M

Create Price Alert on CMMB

Your price alert will notify you when the stock price is above 2.05.

Add to Watchlist